Get started
Author

A. Hillary Steinhart

Observed names: A H Steinhart, A Hilary Steinhart, A Hillary Steinhart, A STEINHART, A Steinhart, A. H. STEINHART, A. Hilary Steinhart, A. Steinhart, A.H. Steinhart, AH Steinhart
Observed institutions: Mount Sinai Hospital, University Health Network, Mayo Clinic, University of Calgary, University of Toronto, Lunenfeld-Tanenbaum Research Institute, Mayo Clinic in Arizona, Sinai Health System
ORCID: 0009-0000-4781-9601
Observed ORCID: 0009-0000-4781-9601
OpenAlex ID: A5111961163
Treatment of left‐sided ulcerative colitis with butyrate enemas: a controlled trial
1996 · A. H. STEINHART, T. HIRUKI, et al. · Alimentary Pharmacology & Therapeutics · 222
Combination of Ciprofloxacin and Metronidazole in Severe Perianal Crohn’s Disease
1993 · MJ Solomon, RS McLeod, et al. · Canadian Journal of Gastroenterology · 145
PDF
Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas.
1994 · A H Steinhart, A Brzezinski, et al. · PubMed · 136
Genetic Variation in Myosin IXB Is Associated With Ulcerative Colitis
2006 · Adriaan A. van Bodegraven, Christine R. Curley, et al. · Gastroenterology · 119
PDF
Risk and significance of endoscopic/radiological evidence of recurrent Crohn's disease
1997 · RS McLeod, BG Wolff, et al. · Gastroenterology · 94
Traditional corticosteroids for induction of remission in Crohn's disease
2007 · EI Benchimol, CH Seow, et al. · Cochrane Database of Systematic Reviews · 70
Absence of linkage between inflammatory bowel disease and selected loci on chromosomes 3, 7, 12, and 16
1998 · J RIOUX, M DALY, et al. · Gastroenterology · 68
PDF
Reliability of a cronh's disease clinical classification scheme based on disease behaviour
1998 · N. Girgrah, R.S. McLeod, et al. · Gastroenterology · 50
PDF
Health‐Related Concerns of People who Receive Psychological Support for Inflammatory Bowel Disease
1997 · Robert G Maunder, Elizabeth C de Rooy, et al. · Canadian Journal of Gastroenterology and Hepatology · 50
PDF
MAST3: a novel IBD risk factor that modulates TLR4 signaling
2008 · C Labbé, P Goyette, et al. · Genes and Immunity · 29
Effect of dietary fiber on total carbohydrate losses in ileostomy effluent.
1992 · A H Steinhart, D J Jenkins, et al. · PubMed · 21
Patients’ Perceptions of their Participation in a Clinical Trial for Postoperative Crohn’s Disease
1998 · ED Kennedy, JE Blair, et al. · Canadian Journal of Gastroenterology and Hepatology · 14
PDF
An SNP linkage scan identifies significant Crohn's disease loci on chromosomes 13q13.3 and, in Jewish families, on 1p35.2 and 3q29
2008 · Y Y Shugart, M S Silverberg, et al. · Genes and Immunity · 11
Total enteral immunomodulatory nutrition (TEIN) treatment for severe active ulcerative colitis
1995 · S.L. Greenbloom, B. Wendland, et al. · Gastroenterology · 11
PDF
Optimal Crohn's disease activity index (CDAI) response criteria is defined by decreaseȦ100 points
2003 · Bruce E. Sands, A. Hilary Steinhart, et al. · Gastroenterology · 10
Treatment of left-sided ulcerative colitis with butyrate enemas: A randomized controlled trial
1995 · A.H. Steinhart, T. Hiruki, et al. · Gastroenterology · 10
PDF
Accelerating Earlier Access to Anti-TNF-α Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease
2025 · Gionata Fiorino, Ashwin Ananthakrishnan, et al. · Journal of Clinical Medicine · 7
Carrier rate of APC I1307K is not increased in inflammatory bowel disease patients of Ashkenazi Jewish origin
2001 · Mark Silverberg, Catherine Clelland, et al. · Human Genetics · 6
6-mercaptopurine and azathioprine for maintenance of remission in ulcerative colitis
1996 · AH Steinhart, CJ Hawkey, et al. · 4
Low bone mineral density (BMD) in Crohn's disease (CD) occurs independent of corticosteroid use
1998 · M.S. Silverberg, S. Mikolainis, et al. · Gastroenterology · 3
Contribution of HLA class II genes to susceptibility to ulcerative colitis (UC) in a Canadian inflammatory bowel disease (IBD) population
1998 · M.S. Silverberg, J. Murphy, et al. · Gastroenterology · 3
Therapeutic Drug Monitoring for Dose Optimization of Infliximab in Patients With Inflammatory Bowel Disease: An Analysis of Canadian Real‐World Data
2025 · David C. Sealey, Kai Fai Ho, et al. · Canadian Journal of Gastroenterology and Hepatology · 2
PDF
P502 Ulcerative colitis patients on vedolizumab lacking response at induction phase continue to improve over the first 6 months of treatment
2017 · P. Zezos, B. Kabakchiev, et al. · Journal of Crohn s and Colitis · 2
OP29 Peri-natal exposure to parental Crohn’s disease is associated with impaired gut barrier, microbiome composition differences and increased risk of Crohn’s disease
2023 · S H Lee Dr., L Qiu, et al. · Journal of Crohn s and Colitis · 1
Infliximab induces mucosal healing in a proximal to distal direction in acute ulcerative colitis.
2011 · C Seow, A Newman, et al. · Inflammatory Bowel Diseases · 1
PDF
Works count: 38
Citation count: 1,090
H-index: 12
I10-index: 16
Year
Topic
Type